Drugs / polyvalent vaccine-KLH conjugate
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01223235 | Oct 2010 → Sep 2017 | fallopian tube cancer, ovarian cancer, peritoneum cancer | Memorial Sloan Kettering Cancer Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | polyvalent vaccine-KLH conjugate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01223235 ↗ |
| Modality | Vaccine | “polyvalent antigen-KLH plus OPT-821 vaccine construct” PMID 35779095 ↗ Jul 2022 |